Merz Therapeutics announced the FDA approved a label update to expand incobotulinumtoxinA’s pediatric upper limb spasticity ...
A clear look at 10 health conditions Canadians manage with medical cannabis, the real evidence behind each one, and how eligibility actually works in Canada.
Zimmer Biomet Holdings (NYSE:ZBH) agreed to acquire Pacira BioSciences’ FDA cleared iovera pain relief device. The agreement ...
Muscle spasticity is a common and often debilitating consequence of spinal cord injury that can significantly affect mobility and quality of life. Spasticity is a condition in which muscles become ...
Muscle spasticity is a common and often debilitating consequence of spinal cord injury that can significantly affect mobility and quality of life. Spasticity is a condition in which muscles become ...
Pacira’s iovera device uses cold therapy for targeted pain relief. An analyst said the addition complements Zimmer Biomet’s ...
Lexicon Pharmaceuticals LXRX is advancing its cardiometabolic franchise, led by its sole marketed drug, sotagliflozin.
Explore the challenges faced by families in Kerala caring for children with chronic disabilities and the urgent need for ...
Under an expanded medical marijuana program that takes effect today in Georgia, people who qualify for a medical cannabis ...
Pacira to receive up to $140 million with $70 million upfront and up to an additional $70 million in potential future revenue-based milestone ...
On June 29, the Drug Enforcement Administration (DEA) will convene a hearing to consider whether marijuana should finally be ...
The Cilento Initiative on Aging Outcomes, or CIAO, held its 11th annual symposium May 22 at the Sanford Burnham Prebys ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results